Free Trial

Chemed (CHE) Competitors

Chemed logo
$580.52 -0.86 (-0.15%)
Closing price 03:59 PM Eastern
Extended Trading
$582.02 +1.51 (+0.26%)
As of 04:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CHE vs. LH, DGX, DVA, CRVL, AMED, MD, AMN, CCRN, OPCH, and BTSG

Should you be buying Chemed stock or one of its competitors? The main competitors of Chemed include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Option Care Health (OPCH), and BrightSpring Health Services (BTSG).

Chemed vs.

Laboratory Co. of America (NYSE:LH) and Chemed (NYSE:CHE) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, community ranking, dividends and earnings.

Chemed has a net margin of 12.69% compared to Laboratory Co. of America's net margin of 5.73%. Chemed's return on equity of 27.86% beat Laboratory Co. of America's return on equity.

Company Net Margins Return on Equity Return on Assets
Laboratory Co. of America5.73% 15.29% 7.01%
Chemed 12.69%27.86%19.12%

95.9% of Laboratory Co. of America shares are owned by institutional investors. Comparatively, 95.8% of Chemed shares are owned by institutional investors. 0.8% of Laboratory Co. of America shares are owned by insiders. Comparatively, 3.3% of Chemed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Laboratory Co. of America presently has a consensus price target of $268.77, suggesting a potential upside of 22.79%. Chemed has a consensus price target of $667.00, suggesting a potential upside of 14.90%. Given Laboratory Co. of America's higher possible upside, analysts plainly believe Laboratory Co. of America is more favorable than Chemed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Laboratory Co. of America
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.87
Chemed
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Laboratory Co. of America pays an annual dividend of $2.88 per share and has a dividend yield of 1.3%. Chemed pays an annual dividend of $2.00 per share and has a dividend yield of 0.3%. Laboratory Co. of America pays out 32.7% of its earnings in the form of a dividend. Chemed pays out 10.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has increased its dividend for 16 consecutive years.

Laboratory Co. of America received 292 more outperform votes than Chemed when rated by MarketBeat users. Likewise, 64.01% of users gave Laboratory Co. of America an outperform vote while only 63.50% of users gave Chemed an outperform vote.

CompanyUnderperformOutperform
Laboratory Co. of AmericaOutperform Votes
626
64.01%
Underperform Votes
352
35.99%
ChemedOutperform Votes
334
63.50%
Underperform Votes
192
36.50%

Laboratory Co. of America has higher revenue and earnings than Chemed. Laboratory Co. of America is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Laboratory Co. of America$13.01B1.41$746M$8.8224.82
Chemed$2.43B3.49$272.51M$19.9129.16

In the previous week, Chemed had 1 more articles in the media than Laboratory Co. of America. MarketBeat recorded 24 mentions for Chemed and 23 mentions for Laboratory Co. of America. Chemed's average media sentiment score of 1.43 beat Laboratory Co. of America's score of 0.99 indicating that Chemed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Laboratory Co. of America
16 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Chemed
19 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Laboratory Co. of America has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Chemed has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500.

Summary

Chemed beats Laboratory Co. of America on 12 of the 22 factors compared between the two stocks.

Get Chemed News Delivered to You Automatically

Sign up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CHE vs. The Competition

MetricChemedHome health care services IndustryMedical SectorNYSE Exchange
Market Cap$8.48B$2.96B$5.27B$18.41B
Dividend Yield0.34%0.34%5.11%4.23%
P/E Ratio29.3228.8221.6631.00
Price / Sales3.491.10377.2226.06
Price / Cash22.4017.2938.1517.53
Price / Book7.893.276.364.27
Net Income$272.51M-$57.02M$3.20B$1.02B
7 Day Performance-2.03%-4.60%4.07%2.25%
1 Month Performance-4.62%-7.93%-10.26%-8.34%
1 Year Performance-3.92%15.85%10.36%1.75%

Chemed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CHE
Chemed
4.6934 of 5 stars
$580.52
-0.1%
$667.00
+14.9%
-4.3%$8.48B$2.43B29.3314,200Upcoming Earnings
Short Interest ↓
Positive News
LH
Laboratory Co. of America
4.7342 of 5 stars
$223.47
-0.7%
$270.38
+21.0%
+9.2%$18.70B$13.01B25.3475,500Dividend Announcement
DGX
Quest Diagnostics
4.905 of 5 stars
$164.53
+0.7%
$180.60
+9.8%
+29.2%$18.26B$9.87B21.3949,000Upcoming Earnings
Positive News
High Trading Volume
DVA
DaVita
3.7259 of 5 stars
$146.59
-1.9%
$166.33
+13.5%
+9.4%$11.73B$12.82B13.6570,000
CRVL
CorVel
0.9754 of 5 stars
$108.81
-1.5%
N/A+49.2%$5.59B$871.31M64.014,230Positive News
AMED
Amedisys
3.1753 of 5 stars
$91.70
-0.2%
$101.00
+10.1%
+0.7%$3.01B$2.35B36.3920,000Upcoming Earnings
Analyst Forecast
News Coverage
Positive News
MD
Pediatrix Medical Group
2.2302 of 5 stars
$13.11
-3.0%
$17.08
+30.4%
+47.6%$1.12B$2.01B-10.925,170Short Interest ↓
AMN
AMN Healthcare Services
4.1712 of 5 stars
$19.73
-3.2%
$41.17
+108.6%
-67.8%$753.55M$2.98B-5.134,230Analyst Forecast
Analyst Revision
News Coverage
CCRN
Cross Country Healthcare
3.5714 of 5 stars
$14.09
-2.9%
$18.41
+30.6%
-17.1%$462.34M$1.34B-281.742,700Short Interest ↑
Positive News
OPCH
Option Care Health
3.1509 of 5 stars
$32.87
-2.0%
$33.00
+0.4%
+3.0%$5.40B$5.00B27.625,600Short Interest ↑
Positive News
BTSG
BrightSpring Health Services
2.9129 of 5 stars
$17.28
+0.8%
$21.67
+25.4%
+59.0%$3.02B$11.27B-66.4635,000News Coverage
Gap Down

Related Companies and Tools


This page (NYSE:CHE) was last updated on 4/17/2025 by MarketBeat.com Staff
From Our Partners